Ovid Therapeutics Inc.
NASDAQ:OVID
0.7569 (USD) • At close January 14, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||
Current Assets: | ||||||||||
Cash & Cash Equivalents
| 27.042 | 129.001 | 187.798 | 72.034 | 41.897 | 36.49 | 87.126 | 51.94 | 69.944 | 4.847 |
Short Term Investments
| 78.792 | 84.134 | 0 | 0 | 34.842 | 5.011 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 105.833 | 129.001 | 187.798 | 72.034 | 76.739 | 41.501 | 87.126 | 51.94 | 69.944 | 4.847 |
Net Receivables
| 0 | 0 | 0 | 0.142 | 1.131 | 0 | 0 | 0.007 | 0.059 | 0 |
Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.243 | 0 | 0 |
Other Current Assets
| 3.764 | 2.379 | 2.682 | 2.668 | 1.943 | 2.767 | 1.462 | 0.464 | 0.28 | 0.001 |
Total Current Assets
| 109.598 | 131.381 | 190.479 | 74.843 | 79.813 | 44.268 | 88.588 | 52.411 | 70.283 | 4.848 |
Non-Current Assets: | ||||||||||
Property, Plant & Equipment, Net
| 14.663 | 16.071 | 0.243 | 0.136 | 0.068 | 0.07 | 0.052 | 0.044 | 0.03 | 0.001 |
Goodwill
| 0 | -0.039 | -0.096 | 0 | -0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0.183 | 0.261 | 0.26 | 0.319 | 0.467 | 0.392 | 0.124 | 0.11 | 0.019 | 0.003 |
Goodwill and Intangible Assets
| 0.183 | 0.222 | 0.164 | 0.319 | 0.467 | 0.392 | 0.124 | 0.11 | 0.019 | 0.003 |
Long Term Investments
| 17.626 | 5.623 | 1.632 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0.096 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 1.957 | 1.97 | 1.931 | 0.628 | 0.495 | 2.92 | 0.694 | 0.463 | 0.045 | 0.007 |
Total Non-Current Assets
| 34.429 | 23.885 | 4.066 | 1.082 | 1.031 | 3.381 | 0.87 | 0.617 | 0.093 | 0.01 |
Total Assets
| 144.027 | 155.266 | 194.545 | 75.926 | 80.844 | 47.65 | 89.458 | 53.028 | 70.377 | 4.858 |
Liabilities & Equity: | ||||||||||
Current Liabilities: | ||||||||||
Account Payables
| 3.703 | 1.953 | 7.127 | 5.446 | 3.256 | 3.756 | 2.026 | 0.857 | 0.671 | 0.079 |
Short Term Debt
| 1.246 | 0.534 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0 | 0 | 0 | 2.213 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities
| 6.525 | 4.505 | 7.671 | 14.404 | 7.278 | 5.089 | 3.995 | 2.876 | 1.639 | 0.041 |
Total Current Liabilities
| 11.474 | 6.992 | 14.798 | 22.063 | 10.534 | 8.844 | 6.021 | 3.733 | 2.309 | 0.12 |
Non-Current Liabilities: | ||||||||||
Long Term Debt
| 14.756 | 16.002 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 10.17 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 30 | 0 | 0 | 0.061 | 0.287 | 0 | 0 | 0 | 0 | 0 |
Total Non-Current Liabilities
| 44.756 | 16.002 | 0 | 10.231 | 0.287 | 0 | 0 | 0 | 0 | 0 |
Total Liabilities
| 56.23 | 22.993 | 14.798 | 32.294 | 10.82 | 8.844 | 6.021 | 3.733 | 2.309 | 0.12 |
Equity: | ||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.008 | 0.008 | 0.005 |
Common Stock
| 0.071 | 0.07 | 0.07 | 0.066 | 0.055 | 0.025 | 0.025 | 0.02 | 0.01 | 0.02 |
Retained Earnings
| -277.866 | -225.527 | -171.358 | -294.192 | -213.157 | -152.695 | -100.716 | -61.771 | -13.495 | -0.335 |
Accumulated Other Comprehensive Income/Loss
| 0.001 | -0.042 | 0 | 0 | 0.002 | -0.002 | -0.051 | -0.02 | -0.004 | 0 |
Other Total Stockholders Equity
| 365.591 | 357.771 | 351.034 | 337.758 | 283.123 | 191.478 | 184.128 | 85.186 | 81.545 | 5.048 |
Total Shareholders Equity
| 87.797 | 132.273 | 179.746 | 43.632 | 70.024 | 38.805 | 83.437 | 49.294 | 68.067 | 4.738 |
Total Equity
| 87.797 | 132.273 | 179.746 | 43.632 | 70.024 | 38.805 | 83.437 | 49.294 | 68.067 | 4.738 |
Total Liabilities & Shareholders Equity
| 144.027 | 155.266 | 194.545 | 75.926 | 80.844 | 47.65 | 89.458 | 53.028 | 70.377 | 4.858 |